Editorial: Malaria diagnosis by Ogutu, BR
110 EAST AFRICAN MEDICAL JOURNAL March 2005
EDITORIAL
MALARIA DIAGNOSIS
Malaria remains the most significant parasitic disease
affecting man. Prompt and accurate diagnosis of malaria
is the key to cost effective management (1). Since the
identification of Plasmodium parasites in human blood
in 1880, the diagnosis of malaria has remained a hot
bed of scientific discussion. The currently available
diagnostic techniques include microscopy, rapid diagnostic
tests, polymerase chain reaction (PCR), automated flow
cytometry, clinical and presumptive diagnosis. These
diagnostic techniques each have inherent limitations that
have not been fully resolved.
Microscopy is the oldest technique and is referred
to as the "gold standard". There are two forms of
microscopic techniques, the Romanosky stains and the
fluorescent technique. Several stains that have been
used for staining the thick and thin blood films include
Giemsa, Field, Jaswant Singh Bhattacharji, Diff Quick,
May-Guanwald, panoptic, and Leishman and Wright.
Of these, the most commonly used are Giemsa and
Field stain, and of the two Giemsa is the most preferred.
Field stain requires a shorter staining time and is
cheaper, but it has limitations in delineating the features
of Plasmodium for species characteristics and it also
deteriorates rapidly so is not suitable if the slides are
to be stored for long. With the Giemsa stain technique,
there are several factors that can impact the quality of
blood slides such as the source and quality of slides
and stain, the ph of the buffer used, quantity of blood
used, and length of the staining period. These subtle
specificities are critical for species identification, in the
turn-around for slide results, and for the long term
storage of blood slides. There is another drawback with
microscopy, and that is its subjective nature. One must
rely on the competence of the microscopist. As a result,
microscopy is referred to as the "imperfect reference"
(2). No international acceptable standards are available
to reference about slide preparation, stain preparation,
staining technique, slide reading paradigms, results
reporting format, or for who qualifies as a microscopist
to be referred to as an "expert microscopist." Such
standards are difficult to establish because, depending
upon the circumstances, one way of performing
microscopy may be more appropriate than others, based
on the anticipated outcome and use of the data
generated (i.e., the occurrence of false positive can ruin
a prophylactic drug or vaccine trial) (2). When the
results of trials are published, it is essential that the
microscopy techniques used and competency of the
microscopist be reported in order to enable readers to
determine the validity of the study outcome; however,
this is rarely done.
Despite its limitations, the microscopy technique
is the only diagnostic technique that can provide
accurate species identification and quantification of the
parasite load. The confines of this technique has led
to the current drive to set up centres of excellence for
microscopy to help formulate standards for performing
microscopy, and for training and proficiency testing of
microscopists. There are also efforts to improve
microscopy by the use of grid lenses as these can easily
be employed to standardise the method of scanning
fields on a slide and also for parasite quantification.
The use of grid lenses is not widely practiced, and still
requires more validation.
The fluorescent microscopy technique, which
involves staining the blood film with fluorescent dye
(usually acridine dye) or with acridine dye in quantitative
buffy coat (QBC), has been used to identify P. falciparum.
This method is an alternative to non-flourescent
microscopy in malaria endemic areas (3, 4). However,
QBC is expensive, it cannot be used for species
identification and parasite load estimation, and it is
currently not available commercially. An infrequently
used alternative to acridine dye is Rhodamine 123
(R123), but its uptake by the red blood cells is affected
by some antimalarial drugs. The role of fluorescent
techniques for malaria diagnosis remains limited.
The last decade has seen the introduction of rapid
diagnostic techniques (RDT) to improve the speed, and
to simplify, the diagnosis of malaria. These techniques
are based on the capture of Plasmodium specific antigens
in finger prick blood samples, and are marketed as
immunochromatographic kits designed for single sample
use. The antigens commonly targeted are histidine rich
protein 2 (HRP2), a water soluble species-specific
protein that is produced by asexual stages and young
gametocytes of Plasmodium species, and parasite lactate
dehydrogenase (pLDH), a soluble glycolytic enzyme that
is expressed at high levels in asexual stages of malaria
parasites. The RDT kits are available under different
names depending on the manufacturing company. The
techniques are easy to learn and to implement, and so
they are useful in field situations (i.e. epidemics), but
they are more expensive compared to microscopy. One
disadvantage of the RDT is that sensitivity and specificity
declines rapidly in low parasite densities (< 100 parasites
per (µl) (3). Another is the persistence of these antigens
(especially HRP2 which may persist for 14 -21 days)
even if the parasites have been cleared; hence their use
may result in a false positive. These techniques are also
species specific; hence they are not useful in the case
of mixed infections. They can also cross react with other
auto-antibodies, such as rheumatoid factor, resulting in
false positives. And, they cannot be used for parasite
load estimation.
The last decade has seen an expansion in the use
of PCR to diagnose diseases including malaria. The
technique detects circulating parasite DNA, so sensitivity
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and specificity is 100% even at very low parasite
densities (such as 5 parasites per µl). However, because
it is a very expensive technique, requires extensive
training, and the results take longer, its role in clinical
practice has not been evaluated. Even with the
development of quantitative PCR, the use of this
technique for parasite load estimation has not been
elucidated. However, it remains a powerful diagnostic
tool for research purposes.
The automated flow cytometry technique is based
on the fluorescence of malaria pigments in white blood
cells. This technique cannot be used for species
identification or parasite load estimation. It is dependent
on the pigment load in circulation; thus, there is a
greater likelihood that early infections will be missed.
The persistence of pigments in some white blood cells,
such as monocytes, may lead to false positive cases.
Additionally, this technique requires very expensive
instrumentation, and so is out of reach for most health
facilities in resource poor countries. Its role in the
clinical setting has not been evaluated.
The clinical algorithm is the most common
diagnostic technique used in malaria endemic areas,
especially in peripheral health facilities where other
diagnostic methods are not available. It is based on the
presumption that the presence of fever equals malaria;
thus, it is quite inaccurate, even when the most stringent
clinical algorithm is applied (5). It is used in malaria
endemic areas for public health purposes to avert
presumed malaria related deaths. It is likely to result
in over treatment, with a resultant increase in drug
pressure. Due to resource constraints, this is the
"diagnostic technique" of last resort when none other
is available.
Presumptive diagnostic technique is a public health
tool that hinges on the fact that a subset of the
population is at increased risk of malaria infection and
poor outcome from the disease. The target population
is more often than not at increased risk of poor outcome
due to the lack of required medical amenities which
enable prompt and accurate diagnosis and treatment.
This diagnosis technique is currently restricted to
pregnant women and children under the age of five
years in malaria endemic areas (6,7). The target
populations are intermittently given a full course of
antimalarial treatment to treat presumed infection, be
it clinical or sub-clinical, and depending on the drug
used, may also be used to provide a prophylactic effect.
Microscopy in the best of hands remains the 'gold
standard' for malaria diagnosis and the other techniques
currently available are there to supplement rather than
replace it. As more validated diagnostic techniques
become available, several factors are likely to influence
the choice of a diagnostic test to be used: the level
of malaria endemicity, first line treatment, prevalence
and type of drug resistance, geographical accessibility,
available health infrastructure, social and economic
factors, and the availability of diagnostic tools. While
we look forward to the development of more robust,
inexpensive, and less subjective techniques with shorter
turn-around times, there is an urgent need to develop
centres of excellence for microscopy to help establish
internationally accepted standards of microscopy and
training of microscopists now.
B. R. Ogutu, MBChB, MMed, PhD, Senior Research
Officer, Walter Reed Project-Centre for Clinical
Research, Kenya Medical Research Institute, P.O. Box
54, Kisumu, Kenya
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